Evaluation of Everolimus Activity against <i>Mycobacterium tuberculosis</i> Using In Vitro Models of Infection
Even though Everolimus has been investigated in a phase II randomized trial as a host-directed therapy (HDT) to treat tuberculosis (TB), an oncological patient treated with Everolimus for a neuroendocrine pancreatic neoplasia developed active TB twice and a non-tuberculous mycobacterial (NTM) infect...
Saved in:
Main Authors: | Delia Mercedes Bianco (Author), Flavio De Maio (Author), Giulia Santarelli (Author), Ivana Palucci (Author), Alessandro Salustri (Author), Giada Bianchetti (Author), Giuseppe Maulucci (Author), Franco Citterio (Author), Maurizio Sanguinetti (Author), Enrica Tamburrini (Author), Michela Sali (Author), Giovanni Delogu (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
First description of the katG gene deletion in a Mycobacterium tuberculosis clinical isolate and its impact on the mycobacterial fitness
by: Flavio De Maio, et al.
Published: (2021) -
Comparison between Nasopharyngeal and Saliva Samples for the Detection of Respiratory Viruses in Children with Acute Lower Respiratory Tract Infections: A Pilot Study
by: Danilo Buonsenso, et al.
Published: (2023) -
Cytoprotective Effects of Punicalagin on Hydrogen-Peroxide-Mediated Oxidative Stress and Mitochondrial Dysfunction in Retinal Pigment Epithelium Cells
by: Maria Elisabetta Clementi, et al.
Published: (2021) -
Everolimus for Compassionate Use in Multiple Basal Cell Carcinomas
by: Laura Eibenschutz, et al.
Published: (2013) -
<i>Mycobacterium</i> Research and Development
Published: (2018)